Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
Open-market buys, last 90 days
$17,224,593
in 1 filing
Open-market sales, last 90 days
$249,372
in 1 filing, $249K under 10b5-1 plans

Net +$16,975,221. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. EcoR1 Capital, LLC +$17.2M Director 1 filing
  2. RENTON HOLLINGS −$249K Director sold 31% of stake
Date Insider Transaction Shares Price Value Owned after
2019-02-08 Lydon Nicholas Director Grant or award · Director Stock Option (Right to Buy) +6,000 6,000
2018-04-16 Lydon Nicholas Director Sale −2,600 $84.18 $219K 301,506
2018-04-16 Lydon Nicholas Director Sale −10,310 $85.11 $877K 291,196
2018-04-16 Lydon Nicholas Director Sale −1,390 $86.15 $120K 289,806
2018-04-16 Lydon Nicholas Director Sale −9,425 $87.46 $824K 280,381
2018-04-16 Lydon Nicholas Director Sale −4,250 $88.30 $375K 276,131
2018-04-16 Lydon Nicholas Director Sale −2,803 $89.42 $251K 273,328
2018-04-16 Lydon Nicholas Director Sale −2,222 $90.26 $201K 271,106
2018-02-15 Lydon Nicholas Director Exercise or conversion +16,483 $4.55 $75K 304,106
2018-02-15 Lydon Nicholas Director Exercise or conversion · Series C Preferred Stock Warrant (right to buy) −16,483 0
2018-02-02 Lydon Nicholas Director Grant or award · Director Stock Option (right to buy) +6,000 6,000
2017-02-24 Lydon Nicholas Director Grant or award · Director Stock Option (right to buy) +15,000 15,000
2017-01-31 Lydon Nicholas Director Conversion +203,625 270,957
2017-01-31 Lydon Nicholas Director Purchase +16,666 $15.00 $250K 287,623
2017-01-31 Lydon Nicholas Director Conversion · Series B Preferred Stock −80,877 0
2017-01-31 Lydon Nicholas Director Conversion · Series C Preferred Stock −55,403 0
2017-01-31 Lydon Nicholas Director Conversion · Series D Preferred Stock −67,345 0

Page 1 of 1 · 17 trades